H

Hansoh Pharmaceutical Group Company Ltd
HKEX:3692

Watchlist Manager
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Watchlist
Price: 17.24 HKD 0.7% Market Closed
Market Cap: 102.3B HKD
Have any thoughts about
Hansoh Pharmaceutical Group Company Ltd?
Write Note

Hansoh Pharmaceutical Group Company Ltd
Total Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Hansoh Pharmaceutical Group Company Ltd
Total Equity Peer Comparison

Comparables:
600196
600436
600276
000538
S
688506

Competitive Total Equity Analysis
Latest Figures & CAGR of Competitors

Company Total Equity CAGR 3Y CAGR 5Y CAGR 10Y
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Total Equity
ÂĄ25.8B
CAGR 3-Years
13%
CAGR 5-Years
60%
CAGR 10-Years
N/A
Shanghai Fosun Pharmaceutical Group Co Ltd
SSE:600196
Total Equity
ÂĄ47B
CAGR 3-Years
7%
CAGR 5-Years
10%
CAGR 10-Years
12%
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Total Equity
ÂĄ13.7B
CAGR 3-Years
17%
CAGR 5-Years
18%
CAGR 10-Years
18%
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Total Equity
ÂĄ42.6B
CAGR 3-Years
9%
CAGR 5-Years
14%
CAGR 10-Years
20%
Yunnan Baiyao Group Co Ltd
SZSE:000538
Total Equity
ÂĄ39.4B
CAGR 3-Years
2%
CAGR 5-Years
2%
CAGR 10-Years
15%
S
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
Total Equity
ÂĄ151.9m
CAGR 3-Years
-30%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Hansoh Pharmaceutical Group Company Ltd's Total Equity?
Total Equity
25.8B CNY

Based on the financial report for Dec 31, 2023, Hansoh Pharmaceutical Group Company Ltd's Total Equity amounts to 25.8B CNY.

What is Hansoh Pharmaceutical Group Company Ltd's Total Equity growth rate?
Total Equity CAGR 5Y
60%

Over the last year, the Total Equity growth was 14%. The average annual Total Equity growth rates for Hansoh Pharmaceutical Group Company Ltd have been 13% over the past three years , 60% over the past five years .

Back to Top